ABOUT PRODUCTS INVESTORS NEWS & EVENTS CAREERS ABOUT Overview Mission & Values Management Team Board of Directors Map & Directions - US Map & Directions - EU Blood Safety for Africa OVERVIEW Cerus Corporation is a biomedical products company focused in the field of blood safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development. About CERUS Mission & Values Investor Overview News & Events Careers Site Map GLOBAL HEADQUARTERS 2550 Stanwell Drive Concord, CA US 94520 +1 925.288.6000 EUROPEAN HEADQUARTERS Stationsstraat 79-D 3811 MH Amersfoort, Netherlands +31 (0) 33 49 60 600 EMAIL ALERTS Alerts are emailed to you when certain new company information is posted to this site. > Sign up now! The INTERCEPT Blood System is not approved for sale in certain countries. Copyright @ 2015 Cerus Corporation. INTERCEPT, INTERCEPT Blood System and Cerus are trademarks of Cerus Corporation. InterSol and Amicus are trademarks of Fenwal, Inc. Privacy Legal Site Map Powered By Q4 Web Systems 4.1.1.49

ABOUT PRODUCTS INVESTORS NEWS & EVENTS CAREERS SITE MAP About Cerus ::Overview ::Mission and Values ::Management Team ::Board of Directors ::Map & Directions US EU ::Blood Safety for Africa Products ::Products Careers ::Careers Overview ::Current Openings US EU News & Events :: Upcoming Events Investors :: Investor Overview :: Corporate Governance :: Analyst Coverage :: Press Releases :: Investor Events :: Webcasts :: Annual Reports :: Annual Meeting :: SEC Filings :: Stock Info :: Email Subscription Form :: Investor Contacts :: RSS Feeds Legal ::Legal ::French Sunshine Act/Decree 2013-414 ::Privacy Policy About CERUS Mission & Values Investor Overview News & Events Careers Site Map GLOBAL HEADQUARTERS 2550 Stanwell Drive Concord, CA US 94520 +1 925.288.6000 EUROPEAN HEADQUARTERS Stationsstraat 79-D 3811 MH Amersfoort, Netherlands +31 (0) 33 49 60 600 EMAIL ALERTS Alerts are emailed to you when certain new company information is posted to this site. > Sign up now! The INTERCEPT Blood System is not approved for sale in certain countries. Copyright @ 2015 Cerus Corporation. INTERCEPT, INTERCEPT Blood System and Cerus are trademarks of Cerus Corporation. InterSol and Amicus are trademarks of Fenwal, Inc. Privacy Legal Site Map Powered By Q4 Web Systems 4.1.1.49